Last checked at 26 Aug 2021 08:48
CVS Group plc
("CVS" or the "Company" and, together with its subsidiaries, the "Group")
Block Listing Application
CVS, one of the UK's leading providers of integrated veterinary services, announces that an application has been made to the Financial Conduct Authority and the London Stock Exchange for the admission of 297,604 of its ordinary shares of 0.2p each in the Company ("Ordinary Shares") to trading on AIM.
The Ordinary Shares will be reserved under a block listing and will be issued in connection with the grant, vesting and/or exercise of awards under the terms of the following employee share schemes:
· 296,069 Ordinary Shares pursuant to the CVS Group plc 2018-2021 SAYE Sharesave Scheme (the "2022 Scheme")
· 1,535 Ordinary Shares pursuant to the CVS Group plc 2017-2020 SAYE Sharesave Scheme (the "2021 Scheme")
When issued, the Ordinary Shares under the block listing will rank pari passu with the Company's existing issued Ordinary Shares. It is anticipated that the shares will be admitted on 1 September 2021.
Contacts: | |
CVS Group plc | via MHP Communications |
Richard Fairman, CEO | |
Jenny Farrer, Company Secretary | |
Singer Capital Markets (Nominated Adviser & Broker) | +44 20 7496 3000 |
Aubrey Powell / Jen Boorer / Rachel Hayes | |
MHP Communications (Financial PR) | +44 20 3128 8549 |
Andrew Jaques / Rachel Mann / Charles Hirst |